Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-266-4972
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2016 - 2019
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2013 - 2016
Nanjing UniversityClass of 2007
Certifications & Licensure
MN State Medical License 2016 - 2025
NJ State Medical License 2014 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma Start of enrollment: 2020 Jun 15
Publications & Presentations
PubMed
- cGAS mRNA-Based Immune Agonist Promotes Vaccine Responses and Antitumor Immunity.Yali Qu, Zhibin Li, Jiahao Yin, He Huang, Jialu Ma
Cancer Immunology Research. 2025-05-02 - Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.Jennifer J Gile, Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal
Experimental Hematology & Oncology. 2025-04-30 - A pilot study to determine the feasibility and safety of pharmacist and nurse driven management of venetoclax ramp-up in patients with chronic lymphocytic leukemia.Rachel J Bailen, Monica I Aasum, Linda M Tamminga, Amber B Koehler, Amy L Behnken
Journal of Oncology Pharmacy Practice. 2025-04-01
Abstracts/Posters
- BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of ProgressionYucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell LymphocytosisYucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Outcomes of stem cell transplant in patients with Richter transformation.2019 ASCO Annual Meeting - 6/1/2019
- Efficacy of frontline treatment regimens in follicular lymphoma: A network meta-analysis of phase III randomized controlled trials.2019 ASCO Annual Meeting - 6/1/2019
- Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
MCL: Event-Free Survival at 2 Years Bodes WellDecember 23rd, 2022- Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status with Survival Benefit of Cancer Immunotherapy in Randomized Clinical TrialsAugust 3rd, 2020
Should Patients with DLBCL and Concurrent FL Be Included in Clinical Trials?August 8th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
